18 Einträge gefunden

1. Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Alpermann, Tamara
   4. Reiter, Andreas
   5. Ulke, Madlen
   6. Dicker, Frank
   7. Eder, Christiane

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
2. Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Eder, Christiane
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Grossmann, Vera
   7. Kohlmann, Alexander

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
3. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.

   1. Bacher, Ulrike
   2. Kern, Wolfgang
   3. Alpermann, Tamara
   4. Schnittger, Susanne
   5. Haferlach, Claudia
   6. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
4. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
5. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

   1. Bacher, Ulrike
   2. Weissmann, Sandra
   3. Kohlmann, Alexander
   4. Schindela, Sonja
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Kern, Wolfgang

   2012 - Forschungsinformationssystem des UKE
6. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.

   1. Haferlach, Claudia
   2. Bacher, Ulrike
   3. Schnittger, Susanne
   4. Alpermann, Tamara
   5. Zenger, Melanie
   6. Kern, Wolfgang
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
7. Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Alpermann, Tamara
   5. Dicker, Frank
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
8. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.

   1. Haferlach, Torsten
   2. Bacher, Ulrike
   3. Alpermann, Tamara
   4. Haferlach, Claudia
   5. Kern, Wolfgang
   6. Schnittger, Susanne

   2012 - Forschungsinformationssystem des UKE
9. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

   1. Bacher, Ulrike
   2. Schnittger, Susanne
   3. Macijewski, Katja
   4. Grossmann, Vera
   5. Kohlmann, Alexander
   6. Alpermann, Tamara
   7. Kowarsch, Andreas

   2012 - Forschungsinformationssystem des UKE
10. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.

    1. Haferlach, Claudia
    2. Bacher, Ulrike
    3. Kohlmann, Alexander
    4. Schindela, Sonja
    5. Alpermann, Tamara
    6. Kern, Wolfgang
    7. Schnittger, Susanne

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
11. Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Kern, Wolfgang
    5. Schnittger, Susanne
    6. Haferlach, Claudia

    2011 - Forschungsinformationssystem des UKE
12. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Kern, Wolfgang
    5. Alpermann, Tamara
    6. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
13. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

    1. Bacher, Ulrike
    2. Haferlach, Claudia
    3. Alpermann, Tamara
    4. Kern, Wolfgang
    5. Schnittger, Susanne
    6. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
14. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Zenger, Melanie
    5. Hochhaus, Andreas
    6. Beelen, Dietrich W
    7. Uppenkamp, Michael

    2011 - Forschungsinformationssystem des UKE
15. Comparison of cytogenetic clonal evolution patterns following allogeneic hematopoietic transplantation versus conventional treatment in patients at relapse of AML.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Zenger, Melanie
    5. Kröger, Nicolaus
    6. Beelen, Dietrich W
    7. Kern, Wolfgang

    2010 - Forschungsinformationssystem des UKE
16. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Kern, Wolfgang
    4. Alpermann, Tamara
    5. Schnittger, Susanne
    6. Haferlach, Claudia

    2010 - Forschungsinformationssystem des UKE
17. Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Dicker, Frank
    4. Kern, Wolfgang
    5. Alpermann, Tamara
    6. Haferlach, Torsten
    7. Haferlach, Claudia

    2010 - Forschungsinformationssystem des UKE
18. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.

    1. Reindl, Lena
    2. Bacher, Ulrike
    3. Dicker, Frank
    4. Alpermann, Tamara
    5. Kern, Wolfgang
    6. Schnittger, Susanne
    7. Haferlach, Torsten

    2010 - Forschungsinformationssystem des UKE